Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 817,635 ordinary shares
- Purchase Date: June 9, 2025
- Highest Price Paid: 405.40 pence per share
- Lowest Price Paid: 396.70 pence per share
- Volume Weighted Average Price: 399.79 pence per share
- Treasury Shares Held: 4,080,205
- Shares with Voting Rights: 8,996,367,761
Material Changes
Following the settlement of the June 9 transaction, the Company's registered share capital stands at 9,000,447,966 ordinary shares of £0.01 each. The number of ordinary shares with voting rights has been updated to 8,996,367,761, a figure shareholders must use for determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. It is a routine disclosure of a share buyback transaction in compliance with the Market Abuse Regulation (Article 5(1)(b) of Regulation (EU) No 596/2014).
Investor Verification Checklist
- Verify the total number of shares purchased (817,635) against the Company's cumulative buyback programme limits.
- Confirm the updated share count with voting rights (8,996,367,761) for regulatory disclosure thresholds.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check the Company's website (www.haleon.com/investors) for the official announcement and trade details.